XML 23 R2.htm IDEA: XBRL DOCUMENT v3.20.4
CONSOLIDATED STATEMENTS OF INCOME - USD ($)
shares in Thousands, $ in Thousands
12 Months Ended
Dec. 31, 2020
Dec. 31, 2019
Dec. 31, 2018
Income Statement [Abstract]      
Net sales $ 3,128,909 $ 3,589,427 $ 3,374,950
Cost of goods sold 2,134,056 2,331,649 2,157,694
Gross profit 994,853 1,257,778 1,217,256
Selling, general and administrative expenses 429,827 533,368 446,090
Research and development expenses 59,214 58,287 70,054
Gain on sale of business 0 0 (210,428)
Operating profit 505,812 666,123 911,540
Interest and financing expenses (73,116) (57,695) (52,405)
Other expenses, net (59,177) (45,478) (64,434)
Income before income taxes and equity in net income of unconsolidated investments 373,519 562,950 794,701
Income tax expense 54,425 88,161 144,826
Income before equity in net income of unconsolidated investments 319,094 474,789 649,875
Equity in net income of unconsolidated investments (net of tax) 127,521 129,568 89,264
Net income 446,615 604,357 739,139
Net income attributable to noncontrolling interests (70,851) (71,129) (45,577)
Net income attributable to Albemarle Corporation $ 375,764 $ 533,228 $ 693,562
Basic earnings per share (in dollars per share) $ 3.53 $ 5.03 $ 6.40
Diluted earnings per share (in dollars per share) $ 3.52 $ 5.02 $ 6.34
Weighted-average common shares outstanding—basic (in shares) 106,402 105,949 108,427
Weighted-average common shares outstanding—diluted (in shares) 106,808 106,321 109,458